Filters: Keyword is Double-Blind Method [Clear All Filters]
"Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial." The Lancet infectious diseases 12, no. 9 (2012): 671-7. Abstract
"Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial." Lancet 371, no. 9631 (2008): 2192-200. Abstract
"Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma." Pediatrics 118, no. 2 (2006): e347-55. Abstract
"Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals." Clinical pharmacokinetics 44, no. 1 (2005): 99-109. Abstract
"Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 11, no. 2 (2002): 111-23. Abstract
"A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298)." AIDS research and human retroviruses 18, no. 10 (2002): 699-704. Abstract
